August 27, 2014 9:29 AM ET

Health Care Technology

Company Overview of Molecular Health AG

Company Overview

Molecular Health AG, a clinico-molecular informatics company, develops precision medicine by translating patient-specific molecular and genomic data, clinical history, and published scientific and medical evidence into drug choices for patients. The company offers clinico-molecular informatics solutions ranging from a drug safety assessment and prediction tool that analyzes the molecular basis of adverse events to a treatment decision support system that transforms genome sequences into evidence-based treatment strategies for cancer patients. Its solutions analyze and synthesize extensive bodies of molecular, biomedical, and clinical evidence; map results to a patient’s clinico-molecular sta...

Dufourstrasse 25

Basel,  4010

Switzerland

Founded in 2004

Phone:

41 61 271 60 34

Fax:

41 61 273 23 70

Key Executives for Molecular Health AG

Chief Executive Officer
Age: 70
Founder and Chairman
Age: 52
Co-Founder
Senior Vice President of Finance
Age: 41
Chief Operating Officer and Executive Vice President
Compensation as of Fiscal Year 2014.

Molecular Health AG Key Developments

MolecularHealth Provides Unprecedented Reimbursement Support with RxAssistance

MolecularHealth announced an important new component of its TreatmentMAP(TM) offering in the United States, called MolecularHealth(TM) RxAssistance. This new service is a value-added benefit for patients and their doctors, providing a level of reimbursement support not previously seen in the molecular diagnostic industry. Unlike reimbursement services offered by other companies that only assess insurance options for the molecular diagnostic test itself, RxAssistance evaluates insurance options for the therapies recommended by its tests. RxAssistance is designed to help streamline the reimbursement process and provide physicians and patients with support and education about payer reimbursement for treatment options. Each patient's TreatmentMAP results report and insurance information is reviewed by MolecularHealth's reimbursement specialist, a Certified Professional Coder(R), prior to results being sent to the physician. Off-label or investigational products recommended for treatment are flagged and information is gathered, including the likelihood a payer will reimburse for the suggested treatments and any additional information that will be needed to receive reimbursement, such as a letter of medical necessity. RxAssistance has been integrated into TreatmentMAP's end-to-end offering and is currently included as a value-added component of all orders. When a physician receives a patient's results report, they also receive an accompanying RxAssistance report, providing information on pre-authorization, patient responsibility for co-pays and deductibles, letters of medical necessity, and step therapy requirements and/or medical benefit formularies.

Molecularhealth Adds Fadi Braiteh to its Advisory Board

MolecularHealth announced the addition of Fadi Braiteh, M.D., to its advisory board. Dr. Braiteh is a practicing oncologist with the Comprehensive Cancer Centers of Nevada, and a leading specialist on gastro-intestinal, digestive system and breast cancer oncology. He joins a board comprised of numerous nationally and internationally-recognized oncology and pathology experts.

MolecularHealth Expands U.S. Sales Team with Three Strategic New Hires

MolecularHealth announced the hiring of three new members of its U.S. sales team, filling the roles of regional vice president and senior account directors. Since the company’s April launch of its cancer treatment decision support offering, TreatmentMAP™, MolecularHealth is seeing increased interest in and demand for its offering, which will be supported by its expanded sales team. The three new additions to the sales team all come with strong backgrounds in pharmaceutical and diagnostics sales, each a former employee of Life Technologies. Matt Brunner, who will report to Dye, boards as regional vice president for the Western region, bringing over 15 years of sales experience, dedicated primarily to oncology. He is joined by Bruce Mrachek and Lee Stuart, who will serve as senior account directors for the Southwest and Southeast regions, respectively.

Similar Private Companies By Industry

Company Name Region
Sanovation AG Europe
Crisalix SA Ltd. Europe
Bitplane AG Europe
Sophia Genetics SA Europe
Molecular Health AG Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Molecular Health AG, please visit www.molecularhealth.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.